恶性胸膜间皮瘤：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访 - Suppr

Suppr

超能文献

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Stahel R A, Weder W, Lievens Y, Felip E

机构信息

Clinic and Policlinic of Oncology, University Hospital of Zürich, Switzerland.

出版信息

Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173.

DOI:10.1093/annonc/mdq173

PMID:20555061

Abstract

摘要

相似文献

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173.

Management of malignant pleural mesothelioma.

Clin Chest Med. 2006 Jun;27(2):335-54. doi: 10.1016/j.ccm.2006.01.004.

Malignant Mesothelioma: Has Anything Changed?

Semin Respir Crit Care Med. 2019 Jun;40(3):347-360. doi: 10.1055/s-0039-1693406. Epub 2019 Sep 16.

Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.

J Thorac Oncol. 2009 Aug;4(8):1010-6. doi: 10.1097/JTO.0b013e3181ae25bf.

Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2008 May;19 Suppl 2:ii43-4. doi: 10.1093/annonc/mdn083.

Malignant pleural mesothelioma.

Cancer Treat Res. 2001;105:327-73. doi: 10.1007/978-1-4615-1589-0_13.

Diagnosis and treatment of malignant pleural mesothelioma.

Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.

Pleura mesothelioma: combined modality treatments.

Ann Oncol. 2002;13 Suppl 4:217-25. doi: 10.1093/annonc/mdf663.

A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.

Ann Thorac Cardiovasc Surg. 2005 Aug;11(4):252-5.

Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma.

Ann Oncol. 2005;16 Suppl 1:i32-3. doi: 10.1093/annonc/mdi835.

引用本文的文献

Malignant peritoneal mesothelioma interactome with 417 novel protein-protein interactions.

BJC Rep. 2024 May 24;2(1):42. doi: 10.1038/s44276-024-00062-w.

Phytochemicals in Malignant Pleural Mesothelioma Treatment-Review on the Current Trends of Therapies.

Int J Mol Sci. 2021 Jul 31;22(15):8279. doi: 10.3390/ijms22158279.

Correlation between CT findings and thoracoscopic diagnosis in diffuse pleural disease.

Acta Biomed. 2020 Sep 7;91(3):e2020058. doi: 10.23750/abm.v91i3.7713.

Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.

J Patient Rep Outcomes. 2017;2(1):16. doi: 10.1186/s41687-018-0039-4. Epub 2018 Mar 27.

Tip60: updates.

J Appl Genet. 2018 May;59(2):161-168. doi: 10.1007/s13353-018-0432-y. Epub 2018 Mar 16.

Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma.

J Thorac Dis. 2018 Jan;10(Suppl 2):S194-S206. doi: 10.21037/jtd.2017.10.12.

Capture of mesothelioma cells with 'universal' CTC-chip.

Oncol Lett. 2018 Feb;15(2):2635-2640. doi: 10.3892/ol.2017.7619. Epub 2017 Dec 14.

Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.

Acta Biomed. 2017 Aug 23;88(2):134-142. doi: 10.23750/abm.v88i2.5558.

Malignant pleural mesothelioma: predictors and staging.

Ann Transl Med. 2017 Jun;5(11):243. doi: 10.21037/atm.2017.06.26.

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.

Respir Res. 2017 Apr 12;18(1):58. doi: 10.1186/s12931-017-0546-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Stahel R A, Weder W, Lievens Y, Felip E

机构信息

Clinic and Policlinic of Oncology, University Hospital of Zürich, Switzerland.

出版信息

Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173.

DOI:10.1093/annonc/mdq173

PMID:20555061

Abstract

摘要

相似文献

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173.

Management of malignant pleural mesothelioma.

Clin Chest Med. 2006 Jun;27(2):335-54. doi: 10.1016/j.ccm.2006.01.004.

Malignant Mesothelioma: Has Anything Changed?

Semin Respir Crit Care Med. 2019 Jun;40(3):347-360. doi: 10.1055/s-0039-1693406. Epub 2019 Sep 16.

Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.

J Thorac Oncol. 2009 Aug;4(8):1010-6. doi: 10.1097/JTO.0b013e3181ae25bf.

Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2008 May;19 Suppl 2:ii43-4. doi: 10.1093/annonc/mdn083.

Malignant pleural mesothelioma.

Cancer Treat Res. 2001;105:327-73. doi: 10.1007/978-1-4615-1589-0_13.

Diagnosis and treatment of malignant pleural mesothelioma.

Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.

Pleura mesothelioma: combined modality treatments.

Ann Oncol. 2002;13 Suppl 4:217-25. doi: 10.1093/annonc/mdf663.

A case of diffuse pleural mesothelioma in which contralateral exploratory thoracoscopy assisted the selection of therapy.

Ann Thorac Cardiovasc Surg. 2005 Aug;11(4):252-5.

Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma.

Ann Oncol. 2005;16 Suppl 1:i32-3. doi: 10.1093/annonc/mdi835.

引用本文的文献

Malignant peritoneal mesothelioma interactome with 417 novel protein-protein interactions.

BJC Rep. 2024 May 24;2(1):42. doi: 10.1038/s44276-024-00062-w.

Phytochemicals in Malignant Pleural Mesothelioma Treatment-Review on the Current Trends of Therapies.

Int J Mol Sci. 2021 Jul 31;22(15):8279. doi: 10.3390/ijms22158279.

Correlation between CT findings and thoracoscopic diagnosis in diffuse pleural disease.

Acta Biomed. 2020 Sep 7;91(3):e2020058. doi: 10.23750/abm.v91i3.7713.

Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.

J Patient Rep Outcomes. 2017;2(1):16. doi: 10.1186/s41687-018-0039-4. Epub 2018 Mar 27.

Tip60: updates.

J Appl Genet. 2018 May;59(2):161-168. doi: 10.1007/s13353-018-0432-y. Epub 2018 Mar 16.

Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma.

J Thorac Dis. 2018 Jan;10(Suppl 2):S194-S206. doi: 10.21037/jtd.2017.10.12.

Capture of mesothelioma cells with 'universal' CTC-chip.

Oncol Lett. 2018 Feb;15(2):2635-2640. doi: 10.3892/ol.2017.7619. Epub 2017 Dec 14.

Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.

Acta Biomed. 2017 Aug 23;88(2):134-142. doi: 10.23750/abm.v88i2.5558.

Malignant pleural mesothelioma: predictors and staging.

Ann Transl Med. 2017 Jun;5(11):243. doi: 10.21037/atm.2017.06.26.

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.

Respir Res. 2017 Apr 12;18(1):58. doi: 10.1186/s12931-017-0546-5.